A detailed history of Citigroup Inc transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 57,305 shares of PTCT stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,305
Previous 31,583 81.44%
Holding current value
$2.59 Million
Previous $965,000 120.31%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.39 - $37.66 $781,691 - $968,690
25,722 Added 81.44%
57,305 $2.13 Million
Q2 2024

Aug 12, 2024

SELL
$24.69 - $40.12 $7.56 Million - $12.3 Million
-306,216 Reduced 90.65%
31,583 $965,000
Q1 2024

May 10, 2024

BUY
$24.15 - $31.95 $2.97 Million - $3.92 Million
122,816 Added 57.13%
337,799 $9.83 Million
Q4 2023

Feb 09, 2024

BUY
$18.07 - $29.37 $142,120 - $230,995
7,865 Added 3.8%
214,983 $5.92 Million
Q3 2023

Nov 09, 2023

BUY
$22.41 - $41.99 $2.62 Million - $4.9 Million
116,800 Added 129.32%
207,118 $4.64 Million
Q2 2023

Aug 10, 2023

SELL
$40.4 - $59.1 $1.45 Million - $2.12 Million
-35,827 Reduced 28.4%
90,318 $3.67 Million
Q1 2023

May 11, 2023

BUY
$38.16 - $48.86 $984,413 - $1.26 Million
25,797 Added 25.71%
126,145 $6.11 Million
Q4 2022

Feb 09, 2023

SELL
$33.53 - $54.79 $741,348 - $1.21 Million
-22,110 Reduced 18.06%
100,348 $3.83 Million
Q3 2022

Nov 10, 2022

SELL
$41.85 - $53.85 $236,326 - $304,090
-5,647 Reduced 4.41%
122,458 $6.15 Million
Q2 2022

Aug 10, 2022

BUY
$25.6 - $45.23 $2.33 Million - $4.12 Million
90,989 Added 245.15%
128,105 $5.13 Million
Q1 2022

May 12, 2022

SELL
$33.33 - $44.6 $3.19 Million - $4.27 Million
-95,752 Reduced 72.07%
37,116 $1.39 Million
Q4 2021

Feb 10, 2022

BUY
$35.36 - $41.86 $2.02 Million - $2.39 Million
57,012 Added 75.16%
132,868 $5.29 Million
Q3 2021

Nov 10, 2021

BUY
$37.01 - $44.74 $2.81 Million - $3.39 Million
75,856 New
75,856 $2.82 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.24B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.